Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma

PURPOSE: This Phase II trial was designed to evaluate the efficacy and safety of docetaxel combined with nedaplatin as first-line treatment for patients with recurrent or metastatic nasopharyngeal carcinoma. METHODS: In this multicenter Phase II trial, the patients were treated with intravenous doce...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Drug Des Devel Ther
Main Authors: Peng, Pei-Jian, Lv, Bao-Jun, Tang, Con, Liao, Hai, Lin, Zhong, Liu, Yu-Meng, Wang, Zhi-Hui, Wang, Si-Yang, Cheng, Zhi-Bin
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4677648/
https://ncbi.nlm.nih.gov/pubmed/26677316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S95946
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados